Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Diagnos (ADK) Stock Price & Analysis

23 Followers

ADK Stock Chart & Stats

CA$0.35-CA$0.02(-1.41%)
At close: 4:00 PM EST
C$0.35C$0.4C$0.45C$0.5Aug 17Aug 31Sep 14Sep 28Oct 13Oct 26Nov 9
Day’s Range
CAD 0.34 - CAD 0.37
52-Week Range
CAD 0.18 - CAD 0.53
Previous Close
CAD 0.36
Volume
N/A
Average Volume (3M)
201.84K
Market Cap
CAD 42.14M
Enterprise Value
CAD 32.59M
Total Cash (Recent Filing)
CAD 1.93M
Total Debt (Recent Filing)
CAD 1.40M
Price to Earnings (P/E)
―
Beta
0.51
Next Earnings
Dec 01, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Diagnostic Technology Focus

Diagnos operates in medical imaging and decision-support, giving it a defined technology focus rather than an undifferentiated business model. If its solutions achieve adoption, software-linked diagnostic capabilities could support scalable commercialization and establish relevance in healthcare information services over time.

Positive Latest Equity Position

The return to positive equity and presence of a 2,390,530 asset base provide some financial foundation despite the company’s broader balance-sheet weakness. This may preserve a degree of operating flexibility and give Diagnos a base from which to pursue commercialization or restructuring efforts.

EPS Growth

Positive reported EPS growth indicates that per-share earnings performance improved on the measured basis, even though the company remains unprofitable overall. If this improvement reflects operational progress rather than a one-time effect, it could support gradual earnings stabilization over the next several quarters.

Bears Say

Severe Revenue Contraction

The sharp decline in revenue shows that Diagnos has not maintained commercial scale across the reported period. Shrinking sales reduce operating leverage, weaken the ability to absorb fixed costs, and make it more difficult for the company to fund product development or reach sustainable breakeven.

Persistent Unprofitability

Large net losses combined with negative gross profit indicate pressure at both the revenue and core economics levels, not merely elevated corporate expenses. Continued losses can constrain investment, erode equity, and make a durable path to profitability harder without meaningful business improvement.

Sustained Cash Burn And Leverage

Persistent negative operating and free cash flow means the business is consuming cash rather than funding itself internally. Combined with debt near twice equity, this raises ongoing external-funding dependence and limits financial flexibility during efforts to restore growth and profitability.

Diagnos News

ADK FAQ

What was Diagnos’s price range in the past 12 months?
Diagnos lowest stock price was C$0.18 and its highest was C$0.53 in the past 12 months.
What is Diagnos’s market cap?
Diagnos’s market cap is C$42.14M.
When is Diagnos’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Diagnos’s earnings last quarter?
Diagnos released its earnings results on Jun 11, 2026. The company reported -C$0.01 earnings per share for the quarter.
Is Diagnos overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Diagnos pay dividends?
Diagnos does not currently pay dividends.
What is Diagnos’s EPS estimate?
Diagnos’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagnos have?
Diagnos has 120,412,550 shares outstanding.
What happened to Diagnos’s price movement after its last earnings report?
Diagnos reported an EPS of -C$0.01 in its last earnings report. Following the earnings report the stock price went down -3%.
Which hedge fund is a major shareholder of Diagnos?
Currently, no hedge funds are holding shares in TSE:ADK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology